Search Results
University of Sydney, Camperdown, New South Wales, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia
Search for other papers by Dahlia F Davidoff in
Google Scholar
PubMed
Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Eugénie S Lim in
Google Scholar
PubMed
University of Sydney, Camperdown, New South Wales, Australia
Search for other papers by Diana E Benn in
Google Scholar
PubMed
Search for other papers by Yuvanaa Subramaniam in
Google Scholar
PubMed
Search for other papers by Eleanor Dorman in
Google Scholar
PubMed
School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
Search for other papers by John R Burgess in
Google Scholar
PubMed
Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
Search for other papers by Scott A Akker in
Google Scholar
PubMed
University of Sydney, Camperdown, New South Wales, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Introduction The phaeochromocytoma and paraganglioma (PPGL) tumour group is the most heritable of tumours, with at least 40% of cases arising from a pathogenic germline mutation ( Dahia 2014 ). Of these, around half are caused by pathogenic
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK
Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Search for other papers by Estelle Healy in
Google Scholar
PubMed
Search for other papers by Philip Weir in
Google Scholar
PubMed
Search for other papers by Madhu Basetti in
Google Scholar
PubMed
Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Search for other papers by Steven J Hunter in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Introduction Primary tumours of adenohypophyseal cells recently suggested to be redefined as pituitary neuroendocrine tumours (PitNETs) can rarely occur in association with paraganglioma (PGL) or phaeochromocytoma. These tumours may develop in
Search for other papers by Robin Schürfeld in
Google Scholar
PubMed
Search for other papers by Christina Pamporaki in
Google Scholar
PubMed
Search for other papers by Mirko Peitzsch in
Google Scholar
PubMed
Search for other papers by Nada Rayes in
Google Scholar
PubMed
Search for other papers by Osama Sabri in
Google Scholar
PubMed
Center of Surgery, Department for Vascular Surgery, Diakonissen Hospital of Leipzig, Leipzig, Germany
Search for other papers by Silvio Rohm in
Google Scholar
PubMed
Search for other papers by Ronald Biemann in
Google Scholar
PubMed
Search for other papers by Benjamin Sandner in
Google Scholar
PubMed
Search for other papers by Anke Tönjes in
Google Scholar
PubMed
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
, et al. 2014 Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions . Clinical Endocrinology 80 478 – 486 . ( https://doi.org/10.1111/cen
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
MN Amar L Prejbisz A Robledo M Taieb D Pacak K Crona J Zelinka T Mannelli M 2020 Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the
Search for other papers by Susan Richter in
Google Scholar
PubMed
Search for other papers by Timothy J Garrett in
Google Scholar
PubMed
Search for other papers by Nicole Bechmann in
Google Scholar
PubMed
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia
Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed
Search for other papers by Hans K Ghayee in
Google Scholar
PubMed
healthcare: a scoping review . npj Digital Medicine 5 2. ( https://doi.org/10.1038/s41746-021-00549-7 ) Eisenhofer G Klink B Richter S Lenders JW & Robledo M 2017 Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach
Search for other papers by Liang Zhang in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension . Journal of Hypertension 38 1443 – 1456 . ( https://doi.org/10.1097/HJH.0000000000002438 ) Li J Wang